West W - Search Results

1

Targeting the p300/CBP Axis in Lethal Prostate Cancer.

Welti J, Sharp A, Brooks N, Yuan W, McNair C, Chand SN, Pal A, Figueiredo I, Riisnaes R, Gurel B, Rekowski J, Bogdan D, West W, Young B, Raja M, Prosser A, Lane J, Thomson S, Worthington J, Onions S, Shannon J, Paoletta S, Brown R, Smyth D, Harbottle GW, Gil VS, Miranda S, Crespo M, Ferreira A, Pereira R, Tunariu N, Carreira S, Neeb AJ, Ning J, Swain A, Taddei D; SU2C/PCF International Prostate Cancer Dream Team; Schiewer MJ, Knudsen KE, Pegg N, de Bono JS. Welti J, et al. Among authors: west w. Cancer Discov. 2021 May;11(5):1118-1137. doi: 10.1158/2159-8290.CD-20-0751. Epub 2021 Jan 11. Cancer Discov. 2021. PMID: 33431496 Free PMC article.

2

Inpatient continuous-infusion interleukin-2 in 788 patients with cancer. The National Biotherapy Study Group experience.

Dillman RO, Church C, Oldham RK, West WH, Schwartzberg L, Birch R. Dillman RO, et al. Among authors: west wh. Cancer. 1993 Apr 1;71(7):2358-70. doi: 10.1002/1097-0142(19930401)71:7<2358::aid-cncr2820710730>3.0.co;2-m. Cancer. 1993. PMID: 8453558

3

Continuous interleukin-2 and lymphokine-activated killer cells for advanced cancer: a National Biotherapy Study Group trial.

Dillman RO, Oldham RK, Tauer KW, Orr DW, Barth NM, Blumenschein G, Arnold J, Birch R, West WH. Dillman RO, et al. Among authors: west wh. J Clin Oncol. 1991 Jul;9(7):1233-40. doi: 10.1200/JCO.1991.9.7.1233. J Clin Oncol. 1991. PMID: 2045864 Clinical Trial.

4

Recombinant interleukin-2 and adoptive immunotherapy alternated with dacarbazine therapy in melanoma: a National Biotherapy Study Group trial.

Dillman RO, Oldham RK, Barth NM, Birch R, Arnold J, West WH. Dillman RO, et al. Among authors: west wh. J Natl Cancer Inst. 1990 Aug 15;82(16):1345-9. doi: 10.1093/jnci/82.16.1345. J Natl Cancer Inst. 1990. PMID: 2199682 Clinical Trial.

5

IL-2: a review of current knowledge.

Oldham RK, Maleckar JR, Yannelli JR, West WH. Oldham RK, et al. Among authors: west wh. Cancer Treat Rev. 1989 Jun;16 Suppl A:5-13. doi: 10.1016/0305-7372(89)90017-0. Cancer Treat Rev. 1989. PMID: 2475252 Review.

6

Enhancement of human lymphokine-activated killer cell cytolysis and a method for increasing lymphokine-activated killer cell yields to cancer patients.

Yannelli JR, Thurman GB, Mrowca-Bastin A, Pennington CS, West WH, Oldham RK. Yannelli JR, et al. Among authors: west wh. Cancer Res. 1988 Oct 15;48(20):5696-700. Cancer Res. 1988. PMID: 3262411

7

High-dose chemotherapy and autologous stem cell transplantation for breast cancer.

Weaver CH, Birch R, Schwartzberg LS, West WH. Weaver CH, et al. Among authors: west wh. Cancer Treat Res. 1995;76:59-85. doi: 10.1007/978-1-4615-2013-9_3. Cancer Treat Res. 1995. PMID: 7577345 Review. No abstract available.

8

Multiple cycles of constant infusion recombinant interleukin-2 in adoptive cellular therapy of metastatic renal carcinoma.

West WH, Tauer KW, Yannelli JR, Marshall GD, Orr D, Lewis M, Birch R, Oldham RK. West WH, et al. Mol Biother. 1989;1(5):268-74. Mol Biother. 1989. PMID: 2619946

9

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.

West WH, Tauer KW, Yannelli JR, Marshall GD, Orr DW, Thurman GB, Oldham RK. West WH, et al. N Engl J Med. 1987 Apr 9;316(15):898-905. doi: 10.1056/NEJM198704093161502. N Engl J Med. 1987. PMID: 3493433

10

Activation and expansion of tumor-derived activated cells for therapeutic use.

Maleckar JR, Friddell CS, Sferruzza A, Thurman GB, Lewko WM, West WH, Oldham RK, Yannelli JR. Maleckar JR, et al. Among authors: west wh. J Natl Cancer Inst. 1989 Nov 1;81(21):1655-60. doi: 10.1093/jnci/81.21.1655. J Natl Cancer Inst. 1989. PMID: 2795694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

485 results

Search Page